1800 202 8726
Reading your sarcoma report

Sarcoma Grading: — What the Numbers on Your Report Mean

A number on your sarcoma pathology report is not a survival score. It describes how the tumour cells look and behave under the microscope — and in sarcoma, that description carries more weight in treatment planning than in almost any other cancer.

Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed September 2026

  • Two systems, one output — FNCLCC and NCI both assign a Grade 1, 2 or 3 using scores for specific features of the tumour tissue.
  • Three features combine — FNCLCC scores differentiation, mitotic count and necrosis, then adds them to reach the final grade.
  • Grade shapes the plan — In sarcoma, grade influences surgery, radiation and chemotherapy decisions alongside stage and location.
  • It is not a survival score — Your oncologist interprets what the grade means for your specific diagnosis and treatment plan.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get this explained properly

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

Sarcomas are graded using FNCLCC or NCI criteria, which score features of the tumour tissue and combine them into a Grade 1, 2 or 3. FNCLCC — the system ESMO recommends — scores three features: differentiation, mitotic count and necrosis. Grade describes the tumour's biology under the microscope, not your prognosis.

FNCLCC versus NCI: how do the two grading systems differ?

FeatureFNCLCC gradingNCI grading
How it worksScores three tumour features and totals themScores two tumour features and totals them
Features scoredDifferentiation, mitotic count, tumour necrosisHistological differentiation, mitotic count
Final grades producedGrade 1, 2 or 3Grade 1, 2 or 3
Primary useSoft tissue sarcomasSoft tissue and some bone sarcomas
Guideline statusRecommended by ESMO for soft tissue sarcomaLess commonly used as the primary system today

What does the FNCLCC system actually measure?

A pathologist scores three features of the tumour tissue separately, then adds the scores to reach a total. That total determines whether the tumour is Grade 1, 2 or 3.

The first feature is differentiation — how closely the tumour cells resemble the normal tissue they came from. The second is the mitotic count — how many cells are caught actively dividing in the tissue sample. The third is necrosis — how much of the tumour consists of dead tissue.

Each feature receives a score. The higher the total, the higher the grade. Your report should state each score and the final grade.

Still unclear?

Send your reports across and a specialist will walk you through what they mean — what is known, what is not, and what the options actually are.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

Why does grade drive treatment more in sarcoma than in most cancers?

In many cancers, staging — how far the disease has spread — is the main guide to treatment. In sarcoma, grade carries equal or greater weight than stage in many guidelines.

A low-grade sarcoma and a high-grade sarcoma of the same size and location may lead to very different treatment plans. Grade influences whether chemotherapy is recommended before or after surgery, whether radiation is part of the plan, and how wide a surgical margin is aimed for.

This is why your pathology report matters so much at diagnosis, and why your treating team will read the grade alongside the stage, subtype and location before recommending anything.

What do the terms on a sarcoma grading report mean?

Histological differentiation
How closely the tumour cells resemble the normal tissue they came from. Well-differentiated cells look more like normal tissue; poorly differentiated cells look very different from it.
Mitotic count (mitotic index)
The number of tumour cells caught actively dividing, counted in a set area of the tissue sample under the microscope. A higher count means more cells are multiplying.
Tumour necrosis
Areas of dead tissue within the tumour. The pathologist records whether necrosis is absent, limited or extensive. A higher necrosis score contributes to a higher total grade.
FNCLCC total score
The number produced when the three feature scores are added together. The final grade is determined from this total.
Grade 1 (low grade)
The lowest total FNCLCC score. Tumour cells appear relatively organised and are dividing slowly.
Grade 2 (intermediate grade)
A mid-range total score. The degree of cellular abnormality and division rate sits between Grade 1 and Grade 3.
Grade 3 (high grade)
The highest total FNCLCC score. Cells appear highly abnormal, are dividing rapidly, and necrosis is often present.

Questions patients ask about sarcoma grading

What is the difference between grade and stage?

Grade describes how the tumour cells look and behave under a microscope. Stage describes where the disease is located in your body — whether it is confined to one site, has reached nearby lymph nodes, or has spread to other organs. Most sarcoma guidelines ask your team to consider both when planning treatment, alongside the subtype, location and size of the tumour. They are two separate measurements, and one does not tell you what the other is.

My report says 'well differentiated' — does that automatically mean Grade 1?

Not always. In FNCLCC grading, differentiation is one of three scored features. The final grade depends on the total of all three scores, so the mitotic count and necrosis score also matter. A tumour can be well differentiated and still receive a Grade 2 if the other scores are elevated. Your report should state the final grade directly — look for 'FNCLCC Grade' or 'histological grade' rather than relying on the differentiation description alone.

Can the grade change between the biopsy and the surgical specimen?

Yes, and this is expected. A biopsy samples only a small part of the tumour. The surgical specimen is the whole tumour, and the pathologist can examine much more of the tissue. If the grade on the surgical specimen differs from the biopsy grade, your team will use the surgical specimen result — it is considered more reliable. For some sarcoma subtypes, a small biopsy is not sufficient to assign a definitive grade, and the final grade is only established after surgery.

Does a high grade mean the cancer has already spread?

No. Grade and stage are separate measurements. A high-grade tumour can be entirely localised — meaning it has not spread beyond its original site. A lower-grade tumour can occasionally have spread by the time it is diagnosed. Your oncologist will give you the grade and the stage as two distinct pieces of information. Understanding both matters; neither alone tells the whole picture.

Does grade alone decide whether I need chemotherapy?

Grade is one input, not the only one. ESMO and NCCN guidance considers grade alongside tumour size, location, subtype and whether the tumour can be removed completely when deciding whether chemotherapy should be discussed. A high grade does not automatically mean chemotherapy will be recommended. A lower grade does not rule it out in every situation. Your oncologist will explain the reasoning behind whatever is proposed for your specific case.

Can I ask for a second opinion on the grading?

Yes, and this is common with sarcomas. Sarcoma is rare, and grading requires experience across a wide range of subtypes. Major cancer guidelines recommend that sarcoma diagnoses be reviewed by a pathologist experienced in sarcoma. You can ask your team to send the biopsy or surgical specimen slides to a specialist pathologist. The original grade is not discarded; it informs the review. Any difference in findings will be discussed with you before any treatment decision changes.

Explore 114 more Waiting For and Understanding Your Report topics

HUB — Cytology and Prostate Scoring Systems Explained

HUB — Understanding Your Biopsy Report

HUB — Waiting for Biopsy Results

All Waiting For and Understanding Your Report →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

What does Grade 3 mean on a sarcoma pathology report?

Grade 3 is the highest grade in the FNCLCC system. It means the tumour received the highest total score when the pathologist scored its differentiation, mitotic count and necrosis. It describes the appearance and activity of the cells under the microscope. Grade is one piece of information your oncologist uses alongside stage, size, location and subtype when planning treatment. Ask your oncologist to explain what this grade means in the context of your specific diagnosis.

What does FNCLCC stand for and why do sarcoma reports use it?

FNCLCC stands for Fédération Nationale des Centres de Lutte Contre le Cancer — the French national cancer network that developed this grading system. It is used because it scores three measurable features of the tumour tissue separately, making it more consistent across different pathologists and laboratories than a single overall impression. ESMO guidelines recommend FNCLCC as the standard grading method for soft tissue sarcomas, which is why most specialist sarcoma reports use it today.

What is a mitotic index and why does it appear on my report?

The mitotic index, also called the mitotic count, is the number of tumour cells caught in the act of dividing, counted in a defined area of the tissue sample under the microscope. In FNCLCC grading, it is one of three scores that contribute to the final grade. A higher count means more cells are actively dividing, which is one signal the pathologist uses when assessing tumour behaviour. The count is taken from areas of the sample where dividing cells are most concentrated.

My report and what the doctor said give different grades — which is correct?

The most reliable grade is the one assigned on the surgical excision specimen, because it gives the pathologist a complete picture rather than a small biopsy sample. If your biopsy grade and surgical grade differ, your oncologist will use the surgical result. If the discrepancy is between your written report and what was said verbally, ask your oncologist to go through the report with you directly. Bring the physical report to your next appointment so both of you are looking at the same document.

Are there sarcoma types where formal grading does not apply?

Yes. Some sarcoma subtypes — including Ewing sarcoma and certain small round cell sarcomas — are defined as high grade as part of their diagnosis, based on their biology rather than through FNCLCC scoring. Your report may note that formal grading does not apply to your subtype, or it may simply not include a grade. If no grade appears on your report, ask your oncologist whether this is because your subtype is already classified by its biology, or because more information is needed.

Can I ask for my sarcoma grading to be reviewed by a specialist?

Yes, and this is both reasonable and encouraged. Sarcoma is rare and the subtypes are numerous; grading accurately requires experience across the full range of sarcoma histology. Most major guidelines recommend specialist pathology review for sarcoma diagnoses. Ask your treating team to arrange this if it has not already been done. Your original slides are sent to the specialist — you do not need another biopsy, and the review adds to the original report rather than replacing it.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation